The 7th Annual Cell and Gene Therapy Innovation Summit #CGTI 2024 is an exclusive gathering for up to 250 pre-qualified decision-makers, intellectual vanguards and captains of industry.

With more regenerative medicine products approaching clinical testing and commercialisation, seize this opportunity to experience in person detailed insights and industry best practices from some of the most renowned CXOs driving and shaping the future of cell and gene therapy. Use code "BIOTREND20" for 20% off at checkout.

Key Speakers Include:

• Uwe Gottschalk, Operating Partner at Keensight Capital - Previous CSO of Lonza
• Cokey Nguyen, CSO of Atara Biotherapeutics
• Gwendolyn Binder, President of Science and Technology at Cabaletta Bio
• Pierre Caloz, COO of uniQure
• Jens H. Vogel, SVP & Global Head of Biotech at Bayer Pharmaceuticals
• Paolo G.V. Martini, CSO International Therapeutics Research Centers, Founder of Moderna Rare Diseases at Moderna

Co-located with: The 16th Annual Bio Innovation Leaders Summit #BILS 2024

To register your interests, please contact Kenzie at hello@cgtsummit.co.uk